Genekam products can be paid in Bitcoin. (basis of conversion rate from bitcoin-exchange)
Genekam has developed human antibodies (true antibodies, therapeutic antibodies) against H5N1 and now we are working to generate sufficient quantity to conduct other assays!
Genekam is developing complex solutions based on antibody conjugates for therapeutic and diagnostic use. The antibodies can be recombinant as well as monoclonal type. Conjugates will be based on beyond the state of art technology. Some of conjugates may have potential to be used as vaccines also.